Personalized Testing & Supplements Market Outlook (2025–2034)
The global Personalized Testing & Supplements Market is on a steady rise as consumers shift toward preventive healthcare and data-driven wellness. From AI-based nutrition analysis to genetic testing and custom supplement formulation, the era of precision health has officially arrived.
Global Market Size:
USD 5.39 Billion (2025) → USD 7.74 Billion (2034)
CAGR: 16.22% (2025–2034)
North America dominates the market with ~40% share (2024).
Asia Pacific is the fastest-growing region with ~20% CAGR expected through 2034.
Genetic Testing Services led with 40% market share in 2024.
Nutrition Supplements held 65% share, remaining the top-selling product type.
Oral Supplements dominated delivery formats (55%), while Functional Foods & Beverages show rapid expansion.
General Wellness applications accounted for 50% of total share, followed by Sports & Fitness at 20%.
Individual Consumers contributed 60% of total end-user share.
Health personalization has moved beyond trends — it’s becoming a cornerstone of modern wellness.
With advances in genomics, microbiome research, and AI-driven analytics, companies are now tailoring supplements and testing kits to the unique biology of each individual.
Wearable biosensors, smart apps, and continuous health tracking are revolutionizing how consumers understand their nutrition and supplement needs.
Role of Artificial Intelligence
AI is the invisible backbone of the personalized testing ecosystem.
From decoding genetic and metabolic data to predicting nutrient deficiencies, AI helps transform complex biological information into actionable wellness insights.
Startups and healthcare tech firms are using machine learning models to:
Analyze DNA and microbiome data
Predict dietary responses
Create real-time, adaptive supplement recommendations
Key Market Growth Drivers
Rising Preventive Health Awareness — Growing consumer focus on nutrition-genomics links fuels demand for personalized wellness.
AI & Data Integration — Artificial intelligence enhances the precision of health assessments.
Digital Health Expansion — Apps, wearables, and connected platforms enable continuous health tracking.
Investment in Nutrigenomics — Global funding from public and private sectors accelerates personalized nutrition R&D.
Global Insights & Metrics
The U.S. recorded $465 million in DTC genetic testing revenue (2022) — the highest globally.
Over 197,000 genetic tests are now available worldwide (2023).
More than 10,000 genetic counselors operate across 45+ countries.
388 million global health app downloads (2024) show rising digital engagement.
Consumers spent $377 million on health apps (2023) — up 19% YoY.
RegionAuthorityKey RegulationFocus Areas🇺🇸 U.S.FDA, FTC, CMSDSHEA, CLIASafety, labeling, consumer protection🇪🇺 EUEFSAIVDR, Nutrition & Health ClaimsDevice certification, scientific claims🇬🇧 UKMHRA, FSAHuman Medicines RegulationsQuality & post-market surveillance🇨🇦 CanadaHealth CanadaNHPR, Food & Drugs ActProduct licensing, supplement safety🇮🇳 IndiaFSSAI, ICMRNutraceutical & Genetic Testing RegulationsLicensing, lab accreditation🇯🇵 JapanMHLW, PMDAPMD Act, Health Promotion ActFunctional food approval, diagnostics
Nutrition Supplements (65%) — Remains dominant, driven by rising preventive wellness adoption.
Personalized Testing Kits — Growing rapidly due to advancements in genomics and AI-based diagnostics.
Genetic Testing Services (40%) — Popular for DNA-based nutrition plans.
Consultation & Recommendations — Fastest-growing segment due to telehealth integration.
Oral Supplements (55%) — Most preferred for convenience and dosage control.
Functional Foods & Beverages — Growing swiftly, blending nutrition with lifestyle appeal.
General Wellness (50%) — Dominant as holistic health awareness grows.
Sports & Fitness (20%) — Expanding fast with tech-led performance optimization.
Individual Consumers (60%) — Main adopters of DTC health solutions.
Healthcare & Clinics — Gaining traction through personalized medicine models.
Leads with ~40% market share in 2024.
Over 26 million adults in the U.S. have used at-home genetic test kits.
Rapid adoption of at-home genetic and biomarker testing (3.2M users in 2022).
Rising health-conscious middle class driving demand.
Innovation hub in Europe — backed by strong healthcare infrastructure and consumer awareness.
Notable growth driven by nutrigenomics research and preventive health programs.
Genetic & Biomarker Data Collection – 23andMe, MyHeritage, Color Genomics
Data Analysis & AI Insights – Viome, Nutrigenomix, DNAfit
Personalized Formulation – Persona Nutrition, Rootine, Baze
Product Packaging & Delivery – Subscription-based supplement models
Digital Engagement – Apps & wearables for real-time tracking
Viome Life Sciences – AI-driven microbiome analysis and precision supplements
DSM-Firmenich – Personalized nutrition via bioscience innovation
Thorne HealthTech – Biomarker-based diagnostics and supplement design
Pharmavite (Nature Made) – Data-integrated supplement personalization
Nestlé Health Science – Global leader via Persona Nutrition and Vital Proteins
GNC Holdings – Lifestyle-based DNA nutrition plans
The Vitamin Shoppe – Retail + digital hybrid personalized wellness
myDNA & Nutrigenomix – Genomic analysis platforms for nutrition planning
The Future of Precision Wellness
The intersection of AI, genomics, and personalized nutrition is redefining how consumers approach health.
As people seek data-backed, science-driven, and lifestyle-synced wellness solutions, the market is poised for exponential expansion by 2034.